Publication

Impact of age, number of cycles of chemotherapy and presence of visceral metastases on PSA response in patients on triplet therapy (ADT + darolutamide + docetaxel) for mHSPC: UK real world data from the RECOMMEND study

Bahl, Amit
; 
Challapalli, Amarnath
; 
Sharma, Anand
; 
Das, Prantik
; 
Bhana, Rajanee
; 
Birtle, Alison
; 
Muthukumar, Dakshinmoorthy
; 
Randhawa, Manreet
; 
Sundar, Santhanam
; 
Renninson, Emily
Glos Author
Renninson, Emily
Date
2026-03-02
Journal Title
Journal of Clinical Oncology (JCO)
Subject
Urology
 Oncology
Type
Conference Abstract
Engagement
Google Scholar:
Lookup
Altmetric:
Collections
Urology
Show all metadata
Abstract
No abstract available
Citation
Bahl et al (2026). Impact of age, number of cycles of chemotherapy and presence of visceral metastases on PSA response in patients on triplet therapy (ADT + darolutamide + docetaxel) for mHSPC: UK real world data from the RECOMMEND study. Journal of Clinical Oncology 44, 67-67. 10.1200/JCO.2026.44.7_suppl.67
Registration number
DOI
10.1200/JCO.2026.44.7_suppl.67
URI
https://hdl.handle.net/20.500.14709/1482
License
Free access to article on publisher's webpage. Click DOI.
Usage rights
Free access to article on publisher's webpage. Click DOI.
License